Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)

被引:19
作者
Fudim, Marat [1 ]
Parikh, Kishan S. [1 ]
Dunning, Allison [1 ]
DeVore, Adam D. [1 ]
Mentz, Robert J. [1 ]
Schulte, Phillip J. [2 ]
Armstrong, Paul W. [3 ]
Ezekowitz, Justin A. [3 ]
Tang, W. H. Wilson [4 ]
McMurray, John J. V. [5 ]
Voors, Adriaan A. [6 ]
Drazner, Mark H. [7 ]
O'Connor, Christopher M. [8 ]
Hernandez, Adrian F. [1 ]
Patel, Chetan B. [1 ]
机构
[1] Duke Clin Res Inst, Durham, NC 27705 USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada
[4] Cleveland Clin, Dept Cardiol, Cleveland, OH 44106 USA
[5] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[6] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[7] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA
[8] Inova Heart & Vasc Inst, Falls Church, VA USA
关键词
WEIGHT CHANGE; RENAL-FUNCTION; CONGESTION; HOSPITALIZATION; PATIENT; ASSOCIATION; RELIABILITY; PRESSURE; INSIGHTS; EDEMA;
D O I
10.1016/j.amjcard.2018.07.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We aimed to study whether jugular venous distension (JVD) and peripheral edema were associated with worse outcomes in patients with acute heart failure in the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure trial. Of 7,141 patients in Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure, 7,135 had complete data on baseline JVD and peripheral edema status. Patients were grouped according to baseline examination findings: (1) no JVD or peripheral edema; (2) JVD only; (3) peripheral edema only; (4) JVD and peripheral edema. We used unadjusted and adjusted logistic or Cox regression analyses to assess associations between groups and the outcomes of index length of stay (LOS), in-hospital mortality, 30- and 180-day all-cause mortality. Patients with peripheral edema (Groups 3 and 4) had higher body mass index, NT-proBNP and BNP values, and more co-morbid disease, and reduced left ventricular ejection fraction compared with patients in Groups 1-2. The median (25th-75th) LOS for Groups 1-4 was 6 (4-9), 5 (4-8), 7 (4-11), and 6 days (4-10), respectively. For the 30-day and 180-day outcomes, adjusted analyses found no significant difference in risk for patients presenting with JVD only or peripheral edema only as compared with patients without evidence of JVD or peripheral edema (p >0.05 for all). The presence of both JVD and peripheral edema was associated with an adjusted 24% increase in risk for all-cause mortality at 30 days, but no risk difference at 180 days. In conclusion, in patients with heart failure presenting to the hospital with dyspnea, the presence of peripheral edema is associated with a longer hospital LOS, but no difference in short- and long-term clinical outcomes when compared with patients wihout peripheral edema. The combination of peripheral edema and JVD identifies the highest risk cohort for poor clinical outcomes. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:1506 / 1512
页数:7
相关论文
共 35 条
  • [1] Adamson Philip B, 2009, Curr Heart Fail Rep, V6, P287
  • [2] Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial
    Ambrosy, Andrew P.
    Cerbin, Lukasz P.
    Armstrong, Paul W.
    Butler, Laved
    Coles, Adrian
    DeVore, Adam D.
    Dunlap, Mark E.
    Ezekowitz, Justin A.
    Felker, G. Michael
    Fudim, Marat
    Greene, Stephen J.
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Schulte, Philip
    Starling, Randall C.
    Teerlink, John R.
    Voors, Adriaan A.
    Mentz, Robert J.
    [J]. JACC-HEART FAILURE, 2017, 5 (01) : 1 - 13
  • [3] The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF
    Ambrosy, Andrew P.
    Hernandez, Adrian F.
    Armstrong, Paul W.
    Butler, Javed
    Dunning, Allison
    Ezekowitz, Justin A.
    Felker, G. Michael
    Greene, Stephen J.
    Kaul, Padma
    McMurray, John J.
    Metra, Marco
    O'Connor, Christopher M.
    Reed, Shelby D.
    Schulte, Phillip J.
    Starling, Randall C.
    Tang, W. H. Wilson
    Voors, Adriaan A.
    Mentz, Robert J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (03) : 306 - 313
  • [4] Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
    Ambrosy, Andrew P.
    Pang, Peter S.
    Khan, Sadiya
    Konstam, Marvin A.
    Fonarow, Gregg C.
    Traver, Brian
    Maggioni, Aldo P.
    Cook, Thomas
    Swedberg, Karl
    Burnett, John C., Jr.
    Grinfeld, Liliana
    Udelson, James E.
    Zannad, Faiez
    Gheorghiade, Mihai
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (11) : 835 - 843
  • [5] Relation of unrecognized hypervolemia in chronic heart failure to clinical status,hemodynamics, and patient outcomes
    Androne, AS
    Hryniewicz, K
    Hudaihed, A
    Mancini, D
    Lamanca, J
    Katz, SD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (10) : 1254 - 1259
  • [6] CLINICAL, RADIOGRAPHIC, AND HEMODYNAMIC CORRELATIONS IN CHRONIC CONGESTIVE-HEART-FAILURE - CONFLICTING RESULTS MAY LEAD TO INAPPROPRIATE CARE
    CHAKKO, S
    WOSKA, D
    MARTINEZ, H
    DEMARCHENA, E
    FUTTERMAN, L
    KESSLER, KM
    MYERBURG, RJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 90 (03) : 353 - 359
  • [7] Patterns of weight change preceding hospitalization for heart failure
    Chaudhry, Sarwat I.
    Wang, Yongfei
    Concato, John
    Gill, Thomas M.
    Krumholz, Harlan M.
    [J]. CIRCULATION, 2007, 116 (14) : 1549 - 1554
  • [8] Causes and treatment of oedema in patients with heart failure
    Clark, Andrew L.
    Cleland, John G. F.
    [J]. NATURE REVIEWS CARDIOLOGY, 2013, 10 (03) : 156 - 170
  • [9] Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure A Report From the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study
    Cleland, John G.
    Chiswell, Karen
    Teerlink, John R.
    Stevens, Susanna
    Fiuzat, Mona
    Givertz, Michael M.
    Davison, Beth A.
    Mansoor, George A.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Cotter, Gad
    Metra, Marco
    Massie, Barry M.
    O'Connor, Christopher M.
    [J]. CIRCULATION-HEART FAILURE, 2014, 7 (01) : 76 - 87
  • [10] Fluid overload in acute heart failure - Re-distribution and other mechanisms beyond fluid accumulation
    Cotter, Gad
    Metra, Marco
    Milo-Cotter, Olga
    Dittrich, Howard C.
    Gheorghiade, Mihai
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (02) : 165 - 169